Published On : 22 Aug 2016
QYResearchReports.com announces the addition of a new research report, titled “Europe Cloud Computing in Pharmaceutical Research and Development Market 2016 Industry, Analysis, Research, Share, Growth, Sales, Trends, Supply, Forecast to 2021.” The report evaluates the cloud computing market in pharmaceutical research and development in Europe and also analyzes the fundamental macro and micro-economic factors impacting the development of the market.
In this study, the weaknesses and strengths of the prime players operating in the market have been evaluated through SWOT analysis. In addition, the drivers and impeders impacting the development of the market in Europe have been detailed under this study. In addition, the chief opportunities in cloud computing in the pharmaceutical research and development market in Europe have been highlighted under this report.
The report starts by explaining the importance of cloud computing in the pharmaceutical research and development market. The chain structure of the industry and an industry news analysis have also been presented under this section of the study. At present, the pharmaceutical industry is implementing a number of cutting-edge technologies and the prominent players in the market are streamlining their methods in order to make their operations more efficient.
Innovative products and services are being introduced by the top players operating in the pharmaceutical industry by the use of new cloud computing solutions and technologies, as per this report.
To get sample copy of report visit @ https://www.qyresearchreports.com/sample/sample.php?rep_id=724962&type=E
Information on the key technological concepts in cloud computing such as cloud computing service models, deployment models, and key stakeholders is presented in the following part of the study. Next in the report comes the segmentation of the market. On the basis of core technology, the Europe cloud computing in pharmaceutical research and development market can be categorized into web services, virtualization, and multi-tenancy. In terms of cloud computing service models, the market can be segmented into software as a service (SaaS), infrastructure as a service (IaaS), and platform as a service (PaaS).
Further, the report presents accurate insights into the prime applications of cloud computing in the pharmaceutical research and development market in Europe. A number of pharmaceutical companies are employing cloud data management services, cloud analytics, marketing, and automation for streamlining their operations. In addition, pharmaceutical companies in Europe have been extensively employing cloud computing solutions for managing a wide range of data and providing practical procedures for clinical trials.
In addition, the utilization of cloud services in pharmaceutical research and development has resulted in effectual data management, which has aided new drug discovery. These factors will further augment the utilization of cloud computing in the pharmaceutical research and development market.
In the last part of the study, the chief company operating in the market – Amazon – has been analyzed on key attributes such as product specifications and pictures, company profile, and contact information.